Skip to content

Cognitive Training for Depression

Cognitive Training for Depression

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01936506
Enrollment
21
Registered
2013-09-06
Start date
2010-07-31
Completion date
2012-10-31
Last updated
2013-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Keywords

Cognitive training, Depression

Brief summary

This study is evaluating the effects of two brain training exercises on: memory, cognitive processing and depression symptoms.

Detailed description

There is an urgent public health need to develop more effective and well tolerated treatments for patients with major depressive disorder (MDD); cognitive training interventions aiming to modify cognitive and affective processing abnormalities underlying MDD represent a promising new strategy. This research project translates a well established cognitive bias in major depressive disorder (MDD), working memory bias, into a novel intervention target. In a double-blind, randomized, controlled study, MDD participants undergo 4 weeks of cognitive training sessions, with two sessions per week.

Interventions

Sponsors

Icahn School of Medicine at Mount Sinai
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Primary, current Axis I diagnosis of Major Depressive Disorder according to DSM-IV criteria and Ham-D-17 score between 16-27 * Age 18-55 * Able to give informed consent

Exclusion criteria

* A history of drug or alcohol abuse or dependence (DSM-IV criteria) within 6 months * Visual impairment that would affect the ability to observe the computerized presentation of faces. * Motor impairment that would affect the ability to provide a response by quickly pressing a button. * Lifetime history of Bipolar spectrum disorders or schizophrenia spectrum disorders. * Primary, current Axis I diagnosis other than Major Depressive Disorder * Primary, current Axis II personality disorder. * Currently attending a cognitive-behavioral psychotherapy regimen * Acute suicidal or homicidal risk (evidenced by suicidal or homicidal attempt within 6 months of screening) * Pregnancy in women. Subjects must exhibit no or only moderate alcohol use. Subjects with current excessive use of alcohol (\> 8 ounces/day for men and \> 6 ounces/day for women) are ineligible for participation, as such drug use could confound the results.

Design outcomes

Primary

MeasureTime frameDescription
change in Hamilton Depression Rating Scale (Ham-D)baseline and week 4Change in depression symptom severity at week 4 compared as to baseline

Secondary

MeasureTime frameDescription
change in Self-referential Information Processing Taskbaseline and week 4change in Negative Affective Bias at week 4 as compared to baseline
change in Working Memorybaseline and week 4change in Neurocognition at week 4 as compared to baseline

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026